INDSWFTLAB

Ind-Swift Laboratories Share Price Ind-Swift Laboratories

₹122.9
+4.65 (3.93%)
23 April, 2024 10:18 BSE: 532305 NSE: INDSWFTLABISIN: INE915B01019

Start SIP in Ind-Swift Laboratories

Start SIP

Ind-Swift Laboratories Performance

Day Range

  • Low 119
  • High 125
₹ 122

52 Week Range

  • Low 63
  • High 138
₹ 122
  • Open Price119
  • Previous Close118
  • Volume575479

Ind-Swift Laboratories Share Price

  • Over 1 Month +22.06%
  • Over 3 Month +14.99%
  • Over 6 Month +37.08%
  • Over 1 Year +87.37%

Ind-Swift Laboratories Key Statistics

P/E Ratio 16.4
PEG Ratio 0.1
Market Cap Cr 726
Price to Book Ratio 1.5
EPS 9.5
Dividend 0
Relative Strength Index 54.28
Money Flow Index 75.11
MACD Signal 4.02
Average True Range 7.42
Ind-Swift Laboratories Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 276270299290
Operating Expenses Qtr Cr 222207239234
Operating Profit Qtr Cr 54636056
Depreciation Qtr Cr 1413149
Interest Qtr Cr 21212022
Tax Qtr Cr 561439
Net Profit Qtr Cr 223017-31
IndicatorMar 2023
Total Revenue Annual Cr 1,185
Operating Expenses Annual Cr 930
Operating Profit Annual in Cr 222
Depreciation Cr 57
Interest Annual Cr 92
Tax Annual Cr 37
Net Profit Annual Cr 42
IndicatorMar 2023
Cash from Operating Activity Annual Cr 136
Cash from Investing Activity Annual Cr 3
Cash from Financing Annual Activity Cr -140
Net Cash Flow Annual Cr
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 675
Fixed Assets Annual Cr 595
Total Non Current Assets Annual Cr 714
Total Current Assets Annual Cr 1,074
Total Assets Annual Cr 1,788
IndicatorMar 2023
Book Value Per Share Annual Rs 113
ROE Annual % 9
ROCE Annual % 14
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 22
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 288290310304
Operating Expenses Qtr Cr 236224250240
Operating Profit Qtr Cr 51666065
Depreciation Qtr Cr 1413149
Interest Qtr Cr 21212022
Tax Qtr Cr 471441
Net Profit Qtr Cr 193217-24
IndicatorMar 2023
Total Revenue Annual Cr 1,241
Operating Expenses Annual Cr 978
Operating Profit Annual in Cr 229
Depreciation Cr 57
Interest Annual Cr 92
Tax Annual Cr 39
Net Profit Annual Cr 48
IndicatorMar 2023
Cash from Operating Activity Annual Cr 195
Cash from Investing Activity Annual Cr -13
Cash from Financing Annual Activity Cr -186
Net Cash Flow Annual Cr -4
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 682
Fixed Assets Annual Cr 595
Total Non Current Assets Annual Cr 660
Total Current Assets Annual Cr 1,165
Total Assets Annual Cr 1,824
IndicatorMar 2023
Book Value Per Share Annual Rs 114
ROE Annual % 10
ROCE Annual % 14
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 22

Ind-Swift Laboratories Technicals

EMA & SMA

Current Price
₹122.9
+4.65 (3.93%)
pointer
  • Bullish Moving Average
  • ___
  • 15
  • Bearish Moving Average
  • ___
  • 1
  • 20 Day
  • ₹116.21
  • 50 Day
  • ₹111.08
  • 100 Day
  • ₹106.11
  • 200 Day
  • ₹98.18
  • 20 Day
  • ₹113.45
  • 50 Day
  • ₹110.03
  • 100 Day
  • ₹105.40
  • 200 Day
  • ₹98.74

Ind-Swift Laboratories Resistance and Support

PIVOT
₹118.39
Resistance
First Resistance 120.37
Second Resistance 122.48
Third Resistance 124.47
RSI 54.28
MFI 75.11
MACD Single Line 4.02
MACD 4.04
Support
First Resistance 116.27
Second Resistance 114.28
Third Resistance 112.17

Ind-Swift Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 390,621 16,593,580 42.48
Week 627,884 33,635,759 53.57
1 Month 2,153,686 101,158,615 46.97
6 Month 657,561 34,975,645 53.19

Ind-Swift Laboratories Result Highlights

Ind-Swift Laboratories Synopsis

NSE-Medical-Generic Drugs

Ind-Swift Laboratori is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1151.96 Cr. and Equity Capital is Rs. 59.81 Cr. for the Year ended 31/03/2023. Ind-Swift Laboratories Ltd. is a Public Limited Listed company incorporated on 04/01/1995 and has its registered office in the State of Chandigarh, India. Company’s Corporate Identification Number(CIN) is L24232CH1995PLC015553 and registration number is 015553.
Market Cap 699
Sales 1,136
Shares in Float 3.43
No of funds 5
Yield
Book Value 1.44
U/D Vol ratio 2.1
LTDebt / Equity 151
Alpha 0.15
Beta 1.15

Ind-Swift Laboratories

Owner NameMar-24Dec-23Sep-23Jun-23
Promoters 42%42%42%42%
Foreign Portfolio Investors 0.26%0.31%0.17%0.08%
Individual Investors 30.46%29.27%28.77%29.21%
Others 27.28%28.42%29.06%28.71%

Ind-Swift Laboratories Management

Name Designation
Mr. Navrattan Munjal Chairman & Managing Director
Mr. Himanshu Jain Joint Managing Director
Mr. Rishav Mehta Executive Director
Mr. Sahil Munjal Executive Director
Dr. Ashwani Kumar Vig Independent Director
Mr. Rajinder Kumar Gupta Independent Director
Mr. S P Sharma Independent Director
Ms. Neerja Chathley Independent Woman Director

Ind-Swift Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Ind-Swift Laboratories Corporate Action

Date Purpose Remarks
2024-02-12 Quarterly Results
2023-11-07 Quarterly Results
2023-08-09 Quarterly Results
2023-05-29 Audited Results
2023-02-14 Quarterly Results

Ind-Swift Laboratories MF Shareholding

Name Amount(cr)

Ind-Swift Laboratories FAQs

What is Share Price of Ind-Swift Laboratories ?

Ind-Swift Laboratories share price is ₹122 As on 23 April, 2024 | 10:04

What is the Market Cap of Ind-Swift Laboratories ?

The Market Cap of Ind-Swift Laboratories is ₹726.2 Cr As on 23 April, 2024 | 10:04

What is the P/E ratio of Ind-Swift Laboratories ?

The P/E ratio of Ind-Swift Laboratories is 16.4 As on 23 April, 2024 | 10:04

What is the PB ratio of Ind-Swift Laboratories ?

The PB ratio of Ind-Swift Laboratories is 1.5 As on 23 April, 2024 | 10:04

Q2FY23